

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.79105022 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.50514026 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.28072499 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.94672569 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.84063548 |
| 6 | vocalization behavior (GO:0071625) | 5.54172209 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.46057892 |
| 8 | glutamate secretion (GO:0014047) | 5.44124821 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.33320661 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.30913654 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.25439871 |
| 12 | neuronal action potential propagation (GO:0019227) | 4.96352079 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.96291871 |
| 14 | neurotransmitter secretion (GO:0007269) | 4.90794673 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 4.79267310 |
| 16 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.75810448 |
| 17 | exploration behavior (GO:0035640) | 4.71853631 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.69482881 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.65204337 |
| 20 | protein localization to synapse (GO:0035418) | 4.54611612 |
| 21 | sodium ion export (GO:0071436) | 4.50361715 |
| 22 | gamma-aminobutyric acid transport (GO:0015812) | 4.50112745 |
| 23 | cellular potassium ion homeostasis (GO:0030007) | 4.48181705 |
| 24 | layer formation in cerebral cortex (GO:0021819) | 4.43247864 |
| 25 | regulation of synapse structural plasticity (GO:0051823) | 4.41470706 |
| 26 | glycine transport (GO:0015816) | 4.24316350 |
| 27 | dendritic spine morphogenesis (GO:0060997) | 4.18969377 |
| 28 | proline transport (GO:0015824) | 4.18255044 |
| 29 | synaptic transmission, glutamatergic (GO:0035249) | 4.14156519 |
| 30 | long-term memory (GO:0007616) | 4.09890797 |
| 31 | cerebellar granule cell differentiation (GO:0021707) | 4.07247069 |
| 32 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.06486078 |
| 33 | neuromuscular process controlling posture (GO:0050884) | 4.00019600 |
| 34 | glutamate receptor signaling pathway (GO:0007215) | 3.99973784 |
| 35 | neurotransmitter transport (GO:0006836) | 3.93780437 |
| 36 | positive regulation of membrane potential (GO:0045838) | 3.93331042 |
| 37 | neuron cell-cell adhesion (GO:0007158) | 3.91246031 |
| 38 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.90307251 |
| 39 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.88436692 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.85286107 |
| 41 | neuron-neuron synaptic transmission (GO:0007270) | 3.85225134 |
| 42 | activation of protein kinase A activity (GO:0034199) | 3.83359761 |
| 43 | neuromuscular process controlling balance (GO:0050885) | 3.83045804 |
| 44 | amino acid import (GO:0043090) | 3.74127202 |
| 45 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.73311891 |
| 46 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.72241612 |
| 47 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.69161231 |
| 48 | cell communication by electrical coupling (GO:0010644) | 3.66260016 |
| 49 | regulation of neurotransmitter levels (GO:0001505) | 3.65888363 |
| 50 | negative regulation of cell killing (GO:0031342) | 3.65591711 |
| 51 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.65591711 |
| 52 | regulation of synaptic plasticity (GO:0048167) | 3.61799793 |
| 53 | synaptic vesicle endocytosis (GO:0048488) | 3.54901870 |
| 54 | regulation of postsynaptic membrane potential (GO:0060078) | 3.53849614 |
| 55 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.53693411 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.50746266 |
| 57 | positive regulation of synapse maturation (GO:0090129) | 3.49189130 |
| 58 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.49045025 |
| 59 | transmission of nerve impulse (GO:0019226) | 3.48694348 |
| 60 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46176217 |
| 61 | modulation by symbiont of host defense response (GO:0052031) | 3.46176217 |
| 62 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46176217 |
| 63 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46176217 |
| 64 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46176217 |
| 65 | modulation by symbiont of host immune response (GO:0052553) | 3.46176217 |
| 66 | L-amino acid import (GO:0043092) | 3.43772984 |
| 67 | regulation of ARF protein signal transduction (GO:0032012) | 3.43165083 |
| 68 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.42103033 |
| 69 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.40764443 |
| 70 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.37620840 |
| 71 | auditory behavior (GO:0031223) | 3.34973176 |
| 72 | potassium ion import (GO:0010107) | 3.34492300 |
| 73 | prepulse inhibition (GO:0060134) | 3.33182653 |
| 74 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.32918058 |
| 75 | membrane depolarization during action potential (GO:0086010) | 3.31468570 |
| 76 | neuronal ion channel clustering (GO:0045161) | 3.30678812 |
| 77 | macrophage activation involved in immune response (GO:0002281) | 3.28624763 |
| 78 | response to auditory stimulus (GO:0010996) | 3.27902484 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 3.27790115 |
| 80 | regulation of vesicle fusion (GO:0031338) | 3.27754432 |
| 81 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.22599043 |
| 82 | signal complex assembly (GO:0007172) | 3.21728431 |
| 83 | positive regulation of neurotransmitter transport (GO:0051590) | 3.20897247 |
| 84 | long-term synaptic potentiation (GO:0060291) | 3.20829020 |
| 85 | dendrite morphogenesis (GO:0048813) | 3.19525589 |
| 86 | vesicle transport along microtubule (GO:0047496) | 3.18476999 |
| 87 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.18433079 |
| 88 | neuron recognition (GO:0008038) | 3.17834516 |
| 89 | response to peptidoglycan (GO:0032494) | 3.14929312 |
| 90 | membrane depolarization (GO:0051899) | 3.14754798 |
| 91 | positive regulation of Rap GTPase activity (GO:0032854) | 3.13951606 |
| 92 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.12569113 |
| 93 | neuromuscular process (GO:0050905) | 3.12399707 |
| 94 | cellular sodium ion homeostasis (GO:0006883) | 3.12327551 |
| 95 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.12217368 |
| 96 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.11483743 |
| 97 | potassium ion homeostasis (GO:0055075) | 3.11335449 |
| 98 | dendritic spine organization (GO:0097061) | 3.10974458 |
| 99 | membrane hyperpolarization (GO:0060081) | 3.10886652 |
| 100 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.04986000 |
| 101 | regulation of synaptic transmission (GO:0050804) | 3.03546553 |
| 102 | innervation (GO:0060384) | 3.03398550 |
| 103 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.03230745 |
| 104 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.02992294 |
| 105 | positive regulation of synaptic transmission (GO:0050806) | 3.01925481 |
| 106 | positive regulation of dendritic spine development (GO:0060999) | 3.01805221 |
| 107 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.01103974 |
| 108 | chemosensory behavior (GO:0007635) | 3.00381203 |
| 109 | learning (GO:0007612) | 3.00090905 |
| 110 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.00030248 |
| 111 | social behavior (GO:0035176) | 2.99969778 |
| 112 | intraspecies interaction between organisms (GO:0051703) | 2.99969778 |
| 113 | cerebellar Purkinje cell layer development (GO:0021680) | 2.98170800 |
| 114 | adult walking behavior (GO:0007628) | 2.96897964 |
| 115 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.95589284 |
| 116 | regulation of regulated secretory pathway (GO:1903305) | 2.95538461 |
| 117 | * synaptic transmission (GO:0007268) | 2.95077098 |
| 118 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.93470009 |
| 119 | regulation of beta-amyloid formation (GO:1902003) | 2.93117865 |
| 120 | axonal fasciculation (GO:0007413) | 2.92542141 |
| 121 | regulation of ARF GTPase activity (GO:0032312) | 2.90482979 |
| 122 | cell migration in hindbrain (GO:0021535) | 2.81533520 |
| 123 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.80253510 |
| 124 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.77255255 |
| 125 | regulation of Rap GTPase activity (GO:0032317) | 2.73909676 |
| 126 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.73348099 |
| 127 | regulation of synapse maturation (GO:0090128) | 2.72684488 |
| 128 | detection of other organism (GO:0098543) | 2.72273838 |
| 129 | neutrophil activation involved in immune response (GO:0002283) | 2.69141159 |
| 130 | protein localization to endosome (GO:0036010) | 2.68056564 |
| 131 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.66682724 |
| 132 | regulation of cellular amide metabolic process (GO:0034248) | 2.62822027 |
| 133 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.61443675 |
| 134 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.59199817 |
| 135 | detection of molecule of bacterial origin (GO:0032490) | 2.59152577 |
| 136 | detection of bacterium (GO:0016045) | 2.58966573 |
| 137 | negative regulation of type 2 immune response (GO:0002829) | 2.56739687 |
| 138 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.54388138 |
| 139 | positive regulation of protein dephosphorylation (GO:0035307) | 2.53737222 |
| 140 | regulation of exocytosis (GO:0017157) | 2.53711099 |
| 141 | regulation of leukocyte degranulation (GO:0043300) | 2.52851604 |
| 142 | germinal center formation (GO:0002467) | 2.51937150 |
| 143 | positive regulation of regulated secretory pathway (GO:1903307) | 2.51710556 |
| 144 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.51295250 |
| 145 | response to manganese ion (GO:0010042) | 2.50432964 |
| 146 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.50201141 |
| 147 | detection of external biotic stimulus (GO:0098581) | 2.43592434 |
| 148 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.43401170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.01098981 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11419465 |
| 3 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.06944221 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.06187120 |
| 5 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.92370369 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.91072817 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.86612033 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.80027398 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.80027398 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.74992559 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.73047080 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.65612964 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.64954894 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.56373964 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.51586276 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.49983085 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49064359 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45760223 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.45699982 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40422396 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.40014607 |
| 22 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.38998987 |
| 23 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.36484378 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.25704017 |
| 25 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.25325435 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.23174131 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16586454 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.12527468 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.08605661 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.03338889 |
| 31 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.01513827 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.97925437 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.83770094 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.77798501 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77718744 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.75343873 |
| 37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.74769439 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.72358793 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67996865 |
| 40 | P68_20966046_ChIP-Seq_HELA_Human | 1.67425592 |
| 41 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.61867136 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.61397172 |
| 43 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.61105374 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57474576 |
| 45 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.56814650 |
| 46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.56303739 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54137695 |
| 48 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.52341616 |
| 49 | MYC_22102868_ChIP-Seq_BL_Human | 1.52291634 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50987928 |
| 51 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.48317661 |
| 52 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48091841 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.46436729 |
| 54 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.46152608 |
| 55 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.45168179 |
| 56 | KDM2B_26808549_Chip-Seq_K562_Human | 1.44682677 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43125815 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42864623 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.42091190 |
| 60 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.40589997 |
| 61 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.39995676 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39809882 |
| 63 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.39240579 |
| 64 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.38449542 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38360764 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38355924 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36616499 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36348286 |
| 69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35895830 |
| 70 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34883352 |
| 71 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.33538486 |
| 72 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.33040586 |
| 73 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32440923 |
| 74 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28755243 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28351277 |
| 76 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27844488 |
| 77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25479567 |
| 78 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25237161 |
| 79 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24905465 |
| 80 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23909697 |
| 81 | AR_19668381_ChIP-Seq_PC3_Human | 1.23341104 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.23039618 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22723140 |
| 84 | MAF_26560356_Chip-Seq_TH1_Human | 1.22611208 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22553228 |
| 86 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22183581 |
| 87 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21987192 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20032074 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19499798 |
| 90 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18970942 |
| 91 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.18520422 |
| 92 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.18423997 |
| 93 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16553767 |
| 94 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.15159704 |
| 95 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14864341 |
| 96 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.14540257 |
| 97 | MAF_26560356_Chip-Seq_TH2_Human | 1.13894962 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13191651 |
| 99 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11920818 |
| 100 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09827184 |
| 101 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09154025 |
| 102 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07569602 |
| 103 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06818718 |
| 104 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05880304 |
| 105 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05581092 |
| 106 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05541509 |
| 107 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.05193923 |
| 108 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05113145 |
| 109 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.04826618 |
| 110 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04416149 |
| 111 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04282291 |
| 112 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03922456 |
| 113 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.03872005 |
| 114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02992796 |
| 115 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02408419 |
| 116 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02261649 |
| 117 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.02216513 |
| 118 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.00356018 |
| 119 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.99972517 |
| 120 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99312950 |
| 121 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99140295 |
| 122 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98951352 |
| 123 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97998955 |
| 124 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97985792 |
| 125 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96156487 |
| 126 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95049617 |
| 127 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94972471 |
| 128 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94088870 |
| 129 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93798168 |
| 130 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93732192 |
| 131 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93680897 |
| 132 | P300_19829295_ChIP-Seq_ESCs_Human | 0.91327630 |
| 133 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91224437 |
| 134 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90384878 |
| 135 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89748797 |
| 136 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88039592 |
| 137 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87992292 |
| 138 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.86772386 |
| 139 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86628236 |
| 140 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84605832 |
| 141 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84552546 |
| 142 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84159053 |
| 143 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.84119862 |
| 144 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.83569470 |
| 145 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81610613 |
| 146 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81245254 |
| 147 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81145089 |
| 148 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.80694288 |
| 149 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.80454982 |
| 150 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80173258 |
| 151 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.79754174 |
| 152 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78755699 |
| 153 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78495394 |
| 154 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.77838061 |
| 155 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77392862 |
| 156 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.77244387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.12557280 |
| 2 | MP0003880_abnormal_central_pattern | 4.55557653 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.33280395 |
| 4 | MP0004270_analgesia | 3.80435555 |
| 5 | MP0009745_abnormal_behavioral_response | 3.47441649 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.32922833 |
| 7 | MP0009046_muscle_twitch | 3.31380672 |
| 8 | MP0002064_seizures | 3.28791790 |
| 9 | MP0005423_abnormal_somatic_nervous | 3.07350478 |
| 10 | MP0003303_peritoneal_inflammation | 3.04663462 |
| 11 | MP0001968_abnormal_touch/_nociception | 3.02703703 |
| 12 | MP0003436_decreased_susceptibility_to | 2.86457933 |
| 13 | MP0002822_catalepsy | 2.82405917 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.76243952 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.72691434 |
| 16 | MP0002272_abnormal_nervous_system | 2.71629079 |
| 17 | MP0001486_abnormal_startle_reflex | 2.63254534 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.31686805 |
| 19 | MP0002736_abnormal_nociception_after | 2.26715931 |
| 20 | MP0008569_lethality_at_weaning | 2.25208857 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.21481239 |
| 22 | MP0003724_increased_susceptibility_to | 2.17457824 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.13960219 |
| 24 | MP0001970_abnormal_pain_threshold | 2.08671430 |
| 25 | MP0001440_abnormal_grooming_behavior | 2.07790912 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 2.02920958 |
| 27 | MP0004858_abnormal_nervous_system | 2.01526143 |
| 28 | MP0003329_amyloid_beta_deposits | 1.99347451 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.95904322 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.95295308 |
| 31 | MP0008260_abnormal_autophagy | 1.94521724 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.89326837 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.85636505 |
| 34 | MP0009278_abnormal_bone_marrow | 1.84684942 |
| 35 | MP0002184_abnormal_innervation | 1.77899941 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.70996593 |
| 37 | MP0004885_abnormal_endolymph | 1.70316842 |
| 38 | MP0002419_abnormal_innate_immunity | 1.70269958 |
| 39 | MP0002557_abnormal_social/conspecific_i | 1.69740367 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.66090532 |
| 41 | MP0004924_abnormal_behavior | 1.66090532 |
| 42 | MP0000955_abnormal_spinal_cord | 1.64621034 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.64494550 |
| 44 | MP0003879_abnormal_hair_cell | 1.57590135 |
| 45 | MP0000778_abnormal_nervous_system | 1.55911929 |
| 46 | MP0005646_abnormal_pituitary_gland | 1.54531655 |
| 47 | MP0003633_abnormal_nervous_system | 1.49581278 |
| 48 | MP0005451_abnormal_body_composition | 1.48760900 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.46916774 |
| 50 | MP0006276_abnormal_autonomic_nervous | 1.42340564 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.40969849 |
| 52 | MP0004142_abnormal_muscle_tone | 1.39021468 |
| 53 | MP0005025_abnormal_response_to | 1.38993582 |
| 54 | MP0003787_abnormal_imprinting | 1.36379799 |
| 55 | MP0005166_decreased_susceptibility_to | 1.30582798 |
| 56 | MP0004947_skin_inflammation | 1.26982803 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.26329190 |
| 58 | MP0005000_abnormal_immune_tolerance | 1.24890165 |
| 59 | MP0003631_nervous_system_phenotype | 1.23660888 |
| 60 | MP0001984_abnormal_olfaction | 1.22766847 |
| 61 | MP0001502_abnormal_circadian_rhythm | 1.20843709 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.20553225 |
| 63 | MP0003122_maternal_imprinting | 1.16153899 |
| 64 | MP0003690_abnormal_glial_cell | 1.13565908 |
| 65 | MP0003075_altered_response_to | 1.11795222 |
| 66 | MP0005464_abnormal_platelet_physiology | 1.11321663 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 1.10061224 |
| 68 | MP0006082_CNS_inflammation | 1.09590395 |
| 69 | MP0009785_altered_susceptibility_to | 1.08897929 |
| 70 | MP0002148_abnormal_hypersensitivity_rea | 1.08365333 |
| 71 | MP0008872_abnormal_physiological_respon | 1.07560992 |
| 72 | MP0000678_abnormal_parathyroid_gland | 1.07378946 |
| 73 | MP0003283_abnormal_digestive_organ | 1.06901672 |
| 74 | MP0002653_abnormal_ependyma_morphology | 1.06352083 |
| 75 | MP0002152_abnormal_brain_morphology | 1.06017486 |
| 76 | MP0005058_abnormal_lysosome_morphology | 1.05984400 |
| 77 | MP0000751_myopathy | 1.05511325 |
| 78 | MP0008961_abnormal_basal_metabolism | 1.05308370 |
| 79 | MP0001905_abnormal_dopamine_level | 1.05141867 |
| 80 | MP0001348_abnormal_lacrimal_gland | 1.04436862 |
| 81 | MP0001790_abnormal_immune_system | 1.03450780 |
| 82 | MP0005387_immune_system_phenotype | 1.03450780 |
| 83 | MP0002229_neurodegeneration | 1.02767388 |
| 84 | MP0003045_fibrosis | 1.01804684 |
| 85 | MP0005409_darkened_coat_color | 1.00594513 |
| 86 | MP0000685_abnormal_immune_system | 1.00576085 |
| 87 | MP0003300_gastrointestinal_ulcer | 1.00029056 |
| 88 | MP0002723_abnormal_immune_serum | 0.99581443 |
| 89 | MP0000920_abnormal_myelination | 0.99313768 |
| 90 | MP0002420_abnormal_adaptive_immunity | 0.99157943 |
| 91 | MP0001819_abnormal_immune_cell | 0.98231399 |
| 92 | MP0003123_paternal_imprinting | 0.98178619 |
| 93 | MP0001177_atelectasis | 0.97282987 |
| 94 | MP0008874_decreased_physiological_sensi | 0.95324435 |
| 95 | MP0000013_abnormal_adipose_tissue | 0.94822433 |
| 96 | MP0000569_abnormal_digit_pigmentation | 0.93756006 |
| 97 | MP0002069_abnormal_eating/drinking_beha | 0.92725676 |
| 98 | MP0003634_abnormal_glial_cell | 0.92503064 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.92479108 |
| 100 | MP0000604_amyloidosis | 0.91772804 |
| 101 | MP0003878_abnormal_ear_physiology | 0.91436605 |
| 102 | MP0005377_hearing/vestibular/ear_phenot | 0.91436605 |
| 103 | MP0004130_abnormal_muscle_cell | 0.90614561 |
| 104 | MP0003632_abnormal_nervous_system | 0.90204069 |
| 105 | MP0005535_abnormal_body_temperature | 0.88465861 |
| 106 | MP0001529_abnormal_vocalization | 0.87757747 |
| 107 | MP0002132_abnormal_respiratory_system | 0.86544005 |
| 108 | MP0002249_abnormal_larynx_morphology | 0.86248225 |
| 109 | MP0010386_abnormal_urinary_bladder | 0.85554287 |
| 110 | MP0001800_abnormal_humoral_immune | 0.83786624 |
| 111 | MP0001835_abnormal_antigen_presentation | 0.81863345 |
| 112 | MP0005076_abnormal_cell_differentiation | 0.80668739 |
| 113 | MP0004085_abnormal_heartbeat | 0.80664002 |
| 114 | MP0001851_eye_inflammation | 0.80374622 |
| 115 | MP0002452_abnormal_antigen_presenting | 0.80065379 |
| 116 | MP0004742_abnormal_vestibular_system | 0.77831458 |
| 117 | MP0003172_abnormal_lysosome_physiology | 0.77228959 |
| 118 | MP0005551_abnormal_eye_electrophysiolog | 0.74884349 |
| 119 | MP0004510_myositis | 0.73851089 |
| 120 | MP0001963_abnormal_hearing_physiology | 0.73344924 |
| 121 | MP0009764_decreased_sensitivity_to | 0.71673930 |
| 122 | MP0001545_abnormal_hematopoietic_system | 0.71344889 |
| 123 | MP0005397_hematopoietic_system_phenotyp | 0.71344889 |
| 124 | MP0003137_abnormal_impulse_conducting | 0.70853657 |
| 125 | MP0000858_altered_metastatic_potential | 0.69619275 |
| 126 | MP0002090_abnormal_vision | 0.69528776 |
| 127 | MP0005394_taste/olfaction_phenotype | 0.67251157 |
| 128 | MP0005499_abnormal_olfactory_system | 0.67251157 |
| 129 | MP0005671_abnormal_response_to | 0.67247881 |
| 130 | MP0005623_abnormal_meninges_morphology | 0.66981135 |
| 131 | MP0002998_abnormal_bone_remodeling | 0.66894095 |
| 132 | MP0002752_abnormal_somatic_nervous | 0.66471494 |
| 133 | MP0003866_abnormal_defecation | 0.65972521 |
| 134 | MP0000716_abnormal_immune_system | 0.65682412 |
| 135 | MP0004043_abnormal_pH_regulation | 0.65294979 |
| 136 | MP0004215_abnormal_myocardial_fiber | 0.65121929 |
| 137 | MP0001485_abnormal_pinna_reflex | 0.64814242 |
| 138 | MP0001188_hyperpigmentation | 0.63465357 |
| 139 | MP0004484_altered_response_of | 0.61816412 |
| 140 | MP0010234_abnormal_vibrissa_follicle | 0.61586351 |
| 141 | MP0004233_abnormal_muscle_weight | 0.60665147 |
| 142 | MP0001299_abnormal_eye_distance/ | 0.60317042 |
| 143 | MP0002638_abnormal_pupillary_reflex | 0.56051019 |
| 144 | MP0000747_muscle_weakness | 0.54174344 |
| 145 | MP0001664_abnormal_digestion | 0.53937788 |
| 146 | MP0010769_abnormal_survival | 0.53889083 |
| 147 | MP0002837_dystrophic_cardiac_calcinosis | 0.53345355 |
| 148 | MP0000631_abnormal_neuroendocrine_gland | 0.52827731 |
| 149 | MP0001943_abnormal_respiration | 0.51687155 |
| 150 | MP0003956_abnormal_body_size | 0.50953657 |
| 151 | MP0002089_abnormal_postnatal_growth/wei | 0.50651626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.73666296 |
| 2 | Focal motor seizures (HP:0011153) | 7.16766053 |
| 3 | Visual hallucinations (HP:0002367) | 5.79242160 |
| 4 | Focal seizures (HP:0007359) | 5.66533541 |
| 5 | Action tremor (HP:0002345) | 4.81616030 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.61853226 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 4.35244466 |
| 8 | Atonic seizures (HP:0010819) | 4.33304718 |
| 9 | Epileptic encephalopathy (HP:0200134) | 4.21983208 |
| 10 | Febrile seizures (HP:0002373) | 4.14660426 |
| 11 | Ankle clonus (HP:0011448) | 4.04516196 |
| 12 | Absence seizures (HP:0002121) | 3.93523154 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.81691326 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.62693841 |
| 15 | Depression (HP:0000716) | 3.61589362 |
| 16 | Dialeptic seizures (HP:0011146) | 3.55508447 |
| 17 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.50028860 |
| 18 | Poor eye contact (HP:0000817) | 3.44779393 |
| 19 | Papilledema (HP:0001085) | 3.43415492 |
| 20 | Postural instability (HP:0002172) | 3.41589858 |
| 21 | Mutism (HP:0002300) | 3.41548185 |
| 22 | Dysdiadochokinesis (HP:0002075) | 3.34022960 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.31885132 |
| 24 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.28903023 |
| 25 | Abnormality of the lower motor neuron (HP:0002366) | 3.27844634 |
| 26 | Dysmetria (HP:0001310) | 3.26983149 |
| 27 | Ventricular fibrillation (HP:0001663) | 3.26837995 |
| 28 | Anxiety (HP:0000739) | 3.22624663 |
| 29 | Abnormal eating behavior (HP:0100738) | 3.19186707 |
| 30 | Impaired social interactions (HP:0000735) | 3.17573962 |
| 31 | Abnormal social behavior (HP:0012433) | 3.17573962 |
| 32 | Myositis (HP:0100614) | 3.16664304 |
| 33 | Broad-based gait (HP:0002136) | 3.16328884 |
| 34 | Orchitis (HP:0100796) | 3.15064041 |
| 35 | Hemiplegia (HP:0002301) | 3.05749658 |
| 36 | Intention tremor (HP:0002080) | 3.02339877 |
| 37 | Truncal ataxia (HP:0002078) | 3.00288692 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.99140667 |
| 39 | Torticollis (HP:0000473) | 2.95166883 |
| 40 | Urinary urgency (HP:0000012) | 2.95065355 |
| 41 | Recurrent abscess formation (HP:0002722) | 2.93891056 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.87588776 |
| 43 | Genetic anticipation (HP:0003743) | 2.85213851 |
| 44 | Impaired smooth pursuit (HP:0007772) | 2.84246956 |
| 45 | Annular pancreas (HP:0001734) | 2.81568445 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 2.81542982 |
| 47 | Spastic gait (HP:0002064) | 2.77118124 |
| 48 | Focal dystonia (HP:0004373) | 2.74232959 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.72555804 |
| 50 | Optic neuritis (HP:0100653) | 2.72555804 |
| 51 | Scanning speech (HP:0002168) | 2.71921613 |
| 52 | Hemiparesis (HP:0001269) | 2.71665245 |
| 53 | Recurrent bacterial skin infections (HP:0005406) | 2.67965182 |
| 54 | Slow saccadic eye movements (HP:0000514) | 2.67565877 |
| 55 | Obstructive lung disease (HP:0006536) | 2.66390421 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.66390421 |
| 57 | Bradykinesia (HP:0002067) | 2.61555034 |
| 58 | Amblyopia (HP:0000646) | 2.61542975 |
| 59 | Insomnia (HP:0100785) | 2.59354274 |
| 60 | Diplopia (HP:0000651) | 2.58247707 |
| 61 | Abnormality of binocular vision (HP:0011514) | 2.58247707 |
| 62 | Bundle branch block (HP:0011710) | 2.57232734 |
| 63 | Megalencephaly (HP:0001355) | 2.56528250 |
| 64 | Neurofibrillary tangles (HP:0002185) | 2.52179132 |
| 65 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.51289733 |
| 66 | Hypochromic anemia (HP:0001931) | 2.49837526 |
| 67 | Progressive inability to walk (HP:0002505) | 2.49618129 |
| 68 | Dysmetric saccades (HP:0000641) | 2.45211459 |
| 69 | Stereotypic behavior (HP:0000733) | 2.44307559 |
| 70 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.44299686 |
| 71 | Diminished motivation (HP:0000745) | 2.44106667 |
| 72 | Status epilepticus (HP:0002133) | 2.44090175 |
| 73 | Craniofacial dystonia (HP:0012179) | 2.44032566 |
| 74 | Pointed chin (HP:0000307) | 2.43464815 |
| 75 | Cellulitis (HP:0100658) | 2.42551523 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 2.39670449 |
| 77 | Amyloidosis (HP:0011034) | 2.37918079 |
| 78 | Cerebral inclusion bodies (HP:0100314) | 2.37887519 |
| 79 | Episodic fever (HP:0001954) | 2.35744105 |
| 80 | Mediastinal lymphadenopathy (HP:0100721) | 2.33148548 |
| 81 | Impaired vibratory sensation (HP:0002495) | 2.31568848 |
| 82 | Clonus (HP:0002169) | 2.30269557 |
| 83 | Lower limb muscle weakness (HP:0007340) | 2.28388960 |
| 84 | Stomatitis (HP:0010280) | 2.25210450 |
| 85 | Termporal pattern (HP:0011008) | 2.22589002 |
| 86 | Insidious onset (HP:0003587) | 2.22589002 |
| 87 | Pheochromocytoma (HP:0002666) | 2.20806158 |
| 88 | Agitation (HP:0000713) | 2.19236175 |
| 89 | Drooling (HP:0002307) | 2.16768361 |
| 90 | Excessive salivation (HP:0003781) | 2.16768361 |
| 91 | Polygenic inheritance (HP:0010982) | 2.16096680 |
| 92 | Abnormality of saccadic eye movements (HP:0000570) | 2.14613296 |
| 93 | Tetraplegia (HP:0002445) | 2.14434284 |
| 94 | Abnormality of the corticospinal tract (HP:0002492) | 2.13654717 |
| 95 | Cholecystitis (HP:0001082) | 2.13298780 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 2.13298780 |
| 97 | Decreased motor nerve conduction velocity (HP:0003431) | 2.12754767 |
| 98 | Fetal akinesia sequence (HP:0001989) | 2.10469622 |
| 99 | Increased IgE level (HP:0003212) | 2.09806042 |
| 100 | Increased cerebral lipofuscin (HP:0011813) | 2.09786160 |
| 101 | Hyperventilation (HP:0002883) | 2.07238562 |
| 102 | Neuronal loss in central nervous system (HP:0002529) | 2.07212226 |
| 103 | Limb dystonia (HP:0002451) | 2.06706955 |
| 104 | Onion bulb formation (HP:0003383) | 2.06366550 |
| 105 | Epileptiform EEG discharges (HP:0011182) | 2.05414124 |
| 106 | Obstructive sleep apnea (HP:0002870) | 2.04619523 |
| 107 | EEG with generalized epileptiform discharges (HP:0011198) | 2.03457861 |
| 108 | Upper limb amyotrophy (HP:0009129) | 2.01812180 |
| 109 | Distal upper limb amyotrophy (HP:0007149) | 2.01812180 |
| 110 | Gingivitis (HP:0000230) | 2.01090669 |
| 111 | Generalized myoclonic seizures (HP:0002123) | 2.01042214 |
| 112 | Abnormal EKG (HP:0003115) | 2.00344216 |
| 113 | Hypsarrhythmia (HP:0002521) | 1.99361343 |
| 114 | Lower limb asymmetry (HP:0100559) | 1.97735086 |
| 115 | Memory impairment (HP:0002354) | 1.97403590 |
| 116 | Amyotrophic lateral sclerosis (HP:0007354) | 1.96894796 |
| 117 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.96584497 |
| 118 | Rigidity (HP:0002063) | 1.95833986 |
| 119 | Incomplete penetrance (HP:0003829) | 1.95471619 |
| 120 | Gait ataxia (HP:0002066) | 1.95111017 |
| 121 | Rapidly progressive (HP:0003678) | 1.94764633 |
| 122 | Urticaria (HP:0001025) | 1.93013492 |
| 123 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.91308008 |
| 124 | Apathy (HP:0000741) | 1.89222508 |
| 125 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89094178 |
| 126 | Psychosis (HP:0000709) | 1.88306084 |
| 127 | Delusions (HP:0000746) | 1.87611299 |
| 128 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.86599978 |
| 129 | Resting tremor (HP:0002322) | 1.85678465 |
| 130 | Spinal canal stenosis (HP:0003416) | 1.85027647 |
| 131 | Dementia (HP:0000726) | 1.84854866 |
| 132 | Meningitis (HP:0001287) | 1.84367187 |
| 133 | Polyphagia (HP:0002591) | 1.84101818 |
| 134 | Hyperacusis (HP:0010780) | 1.83287204 |
| 135 | Loss of speech (HP:0002371) | 1.80888432 |
| 136 | Neuroendocrine neoplasm (HP:0100634) | 1.80878571 |
| 137 | Hand muscle atrophy (HP:0009130) | 1.79533503 |
| 138 | Prolonged bleeding time (HP:0003010) | 1.79214579 |
| 139 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.79064363 |
| 140 | Bowel incontinence (HP:0002607) | 1.78691355 |
| 141 | Sleep apnea (HP:0010535) | 1.78532304 |
| 142 | Absent speech (HP:0001344) | 1.78473492 |
| 143 | Postural tremor (HP:0002174) | 1.78111124 |
| 144 | Distal sensory impairment (HP:0002936) | 1.77590571 |
| 145 | Lower limb amyotrophy (HP:0007210) | 1.77427734 |
| 146 | Peripheral hypomyelination (HP:0007182) | 1.75792676 |
| 147 | Hyperthyroidism (HP:0000836) | 1.75489118 |
| 148 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.75360354 |
| 149 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.74813017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.36285490 |
| 2 | MAP3K9 | 4.20900868 |
| 3 | EPHA4 | 3.88941578 |
| 4 | MINK1 | 2.95227153 |
| 5 | MAP3K4 | 2.85913140 |
| 6 | MARK1 | 2.83739939 |
| 7 | PRKD3 | 2.70360835 |
| 8 | PAK6 | 2.60121690 |
| 9 | DAPK2 | 2.51249956 |
| 10 | KSR2 | 2.38914564 |
| 11 | MAP3K11 | 2.33236402 |
| 12 | CAMKK1 | 2.32845265 |
| 13 | TRIB3 | 2.31564076 |
| 14 | ERN1 | 2.23933231 |
| 15 | MAP2K7 | 2.19798908 |
| 16 | NTRK1 | 2.08932476 |
| 17 | NTRK2 | 2.07694393 |
| 18 | MAP2K4 | 1.90522570 |
| 19 | MAP3K12 | 1.80283105 |
| 20 | IRAK4 | 1.72160034 |
| 21 | RIPK4 | 1.69382282 |
| 22 | SIK1 | 1.69245754 |
| 23 | MAP2K3 | 1.69199329 |
| 24 | CDK5 | 1.60679402 |
| 25 | SMG1 | 1.55823434 |
| 26 | GRK5 | 1.52259698 |
| 27 | UHMK1 | 1.36713990 |
| 28 | ARAF | 1.34802798 |
| 29 | KSR1 | 1.34289059 |
| 30 | CDK19 | 1.33817976 |
| 31 | MAP3K2 | 1.33169836 |
| 32 | DAPK1 | 1.32994233 |
| 33 | EPHB1 | 1.32419837 |
| 34 | MAP4K1 | 1.31098214 |
| 35 | TYRO3 | 1.28961555 |
| 36 | LMTK2 | 1.27898416 |
| 37 | PINK1 | 1.27130004 |
| 38 | TAOK2 | 1.26256286 |
| 39 | SIK2 | 1.24617166 |
| 40 | PRPF4B | 1.23474977 |
| 41 | FES | 1.22174008 |
| 42 | TAOK1 | 1.21038612 |
| 43 | PRKCG | 1.20399296 |
| 44 | IRAK3 | 1.19003293 |
| 45 | MAP3K3 | 1.18925086 |
| 46 | LATS2 | 1.18856206 |
| 47 | IRAK2 | 1.17512367 |
| 48 | CAMKK2 | 1.17412635 |
| 49 | TNIK | 1.16951613 |
| 50 | PHKG2 | 1.16831269 |
| 51 | PHKG1 | 1.16831269 |
| 52 | MAP3K13 | 1.14471712 |
| 53 | PLK2 | 1.14446259 |
| 54 | BLK | 1.14070867 |
| 55 | ALK | 1.13835092 |
| 56 | MAPK13 | 1.11226549 |
| 57 | SIK3 | 1.10452162 |
| 58 | PRKCH | 1.09794782 |
| 59 | CAMK1 | 1.09464714 |
| 60 | PRKD2 | 1.05233911 |
| 61 | CSK | 1.05059720 |
| 62 | GRK6 | 1.02381891 |
| 63 | STK11 | 1.01612344 |
| 64 | RIPK1 | 1.00933845 |
| 65 | RET | 0.97295600 |
| 66 | MAPK12 | 0.95788965 |
| 67 | CDK15 | 0.94468628 |
| 68 | CDK18 | 0.93280620 |
| 69 | TNK2 | 0.92813167 |
| 70 | PNCK | 0.92613107 |
| 71 | WNK1 | 0.92588475 |
| 72 | SGK494 | 0.92351274 |
| 73 | SGK223 | 0.92351274 |
| 74 | ICK | 0.90575276 |
| 75 | CDK14 | 0.88055873 |
| 76 | CDK11A | 0.83210386 |
| 77 | TYK2 | 0.82306304 |
| 78 | CAMK2A | 0.81333508 |
| 79 | PRKG2 | 0.78497548 |
| 80 | JAK2 | 0.78192860 |
| 81 | PAK3 | 0.77972595 |
| 82 | ZAP70 | 0.77776690 |
| 83 | SGK3 | 0.77426373 |
| 84 | PDK1 | 0.75853908 |
| 85 | NEK1 | 0.73865852 |
| 86 | MAP3K1 | 0.73350923 |
| 87 | BRSK1 | 0.72487673 |
| 88 | TBK1 | 0.71187772 |
| 89 | RAF1 | 0.70987221 |
| 90 | HCK | 0.70945902 |
| 91 | MARK2 | 0.70657175 |
| 92 | CDC42BPA | 0.70463975 |
| 93 | SGK2 | 0.69458335 |
| 94 | BRAF | 0.68290685 |
| 95 | * STK38 | 0.68028249 |
| 96 | PDPK1 | 0.67542746 |
| 97 | FGR | 0.65360315 |
| 98 | CAMK2B | 0.64841882 |
| 99 | HIPK2 | 0.64373074 |
| 100 | SGK1 | 0.62408179 |
| 101 | PTK6 | 0.60912181 |
| 102 | PTK2B | 0.59767583 |
| 103 | SCYL2 | 0.59045597 |
| 104 | DYRK1A | 0.57912791 |
| 105 | TESK1 | 0.56274499 |
| 106 | MAP3K7 | 0.56104443 |
| 107 | OXSR1 | 0.54967373 |
| 108 | RPS6KA3 | 0.54528068 |
| 109 | CAMK1G | 0.53475931 |
| 110 | CSNK1G2 | 0.53205789 |
| 111 | CAMK4 | 0.52748393 |
| 112 | JAK1 | 0.51759106 |
| 113 | MAPK10 | 0.50539175 |
| 114 | NEK6 | 0.50255009 |
| 115 | MAP2K6 | 0.49985985 |
| 116 | CAMK2G | 0.49786180 |
| 117 | PRKCZ | 0.49668488 |
| 118 | SYK | 0.48848274 |
| 119 | DYRK1B | 0.47929471 |
| 120 | FYN | 0.47661924 |
| 121 | CASK | 0.46562051 |
| 122 | FER | 0.43254282 |
| 123 | BMPR2 | 0.40484473 |
| 124 | CAMK2D | 0.40273134 |
| 125 | DAPK3 | 0.39318960 |
| 126 | BMX | 0.38964358 |
| 127 | MAP2K1 | 0.36649712 |
| 128 | RPS6KA2 | 0.36094046 |
| 129 | PRKCE | 0.35424050 |
| 130 | ROCK2 | 0.33813371 |
| 131 | PRKCB | 0.31864306 |
| 132 | MAPKAPK5 | 0.28587491 |
| 133 | DDR2 | 0.28411567 |
| 134 | PRKCA | 0.28401927 |
| 135 | LIMK1 | 0.27936761 |
| 136 | ROCK1 | 0.27818073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.43284896 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.37863086 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.80772416 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.68103699 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.64510488 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.60300217 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.53552974 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.49185012 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.47292903 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.36120687 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.32665809 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.19461026 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.08393496 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.07136399 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.03539882 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.90811431 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89780284 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.85702155 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.78072661 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.66124589 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.63630141 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.62502581 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.62425840 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61629417 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55477782 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.55246242 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.53936630 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.50354071 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50271515 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49747941 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.39848827 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34254604 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.31744562 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.30232131 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.29409220 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28537455 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28366022 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.28024153 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.25646870 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.25195483 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20628247 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19839919 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.19836917 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.18218115 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07998570 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06917988 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06582317 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03482198 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 1.01008320 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00313622 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99277420 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99218243 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96456817 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93283545 |
| 55 | Axon guidance_Homo sapiens_hsa04360 | 0.93181545 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93043932 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92359923 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91313847 |
| 59 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.90760194 |
| 60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90060357 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87896432 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87335093 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87003193 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82521788 |
| 65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82152769 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79720689 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.78555617 |
| 68 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.77864584 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77084277 |
| 70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75787943 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74644362 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73886709 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73654939 |
| 74 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73539454 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73411925 |
| 76 | Bile secretion_Homo sapiens_hsa04976 | 0.72235958 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70682719 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.70480079 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70350287 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69469741 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68944503 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.68461551 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68068163 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.66612466 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.65006503 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64855259 |
| 87 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62883435 |
| 88 | Phototransduction_Homo sapiens_hsa04744 | 0.62426959 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.62110954 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61666822 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61457099 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60794317 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60089120 |
| 94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59396693 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58749513 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58351875 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56622239 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56453013 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56370635 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.56362144 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55316026 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54837134 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54657492 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.53371764 |
| 105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53104451 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52946120 |
| 107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52845098 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47271012 |
| 109 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.45994899 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.45497021 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45026887 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44803467 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44655453 |
| 114 | Alcoholism_Homo sapiens_hsa05034 | 0.44439395 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44237187 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42654382 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40569965 |
| 118 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40231231 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38862416 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.37719109 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37359916 |
| 122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37194029 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36840916 |
| 124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35542427 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34719991 |
| 126 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33051373 |
| 127 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32649192 |
| 128 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32183884 |
| 129 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31262859 |
| 130 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30666293 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27680688 |
| 132 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27213694 |

